Doctor profile · Federal record
Dr. Tawan Khamapirad, M.D.
Ophthalmology Physician (CMS: Ophthalmology) · Ophthalmology Physician · Ophthalmology Physician · Retina Specialist (Ophthalmology) Physician · Retina Specialist (Ophthalmology) Physician · Retina Specialist (Ophthalmology) Physician · Memphis, TN
- NPI 1689679441
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 29 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6005 Park Ave, Ste 624B
Memphis, TN 381195221
(901) 682-1100
fax (901) 682-6915 - Mailing address
-
Po Box 1000 Dept 448
Memphis, TN 381480448
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- April 26, 2017
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (3)
- Tennessee #37817 · Mississippi #18267 · Arkansas #E3846
- Medicaid (2)
- MS #04635763 · TN #3886759
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689679441. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
29,686
Distinct HCPCS
10
Medicare allowed
$4,356,397
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 13,140 | 33 | $37 | |
92134 |
Imaging of retina | 3,856 | 1,108 | $37 | |
67028 |
Injection of drug into eye | 3,221 | 689 | $120 | |
J0178 |
Injection, aflibercept, 1 mg | 2,560 | 219 | $868 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 2,171 | 280 | $269 | |
J9035 |
Injection, bevacizumab, 10 mg | 1,984 | 451 | $71 | |
92014 |
Established patient complete exam of visual system | 1,307 | 885 | $117 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 336 | 226 | $84 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 306 | 16 | $231 | |
J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg | 245 | 11 | $200 |
In context: peer comparison
Among 23 peers in this city , average services per provider: 352. This provider delivers 84× the peer median.Open Payments
Industry payments received
All-time total
$371
Transactions
19
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Alimera Sciences, Inc. | 4 | $88.35 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $69.53 | |
| Genentech USA, Inc. | 4 | $65.15 | |
| ABBVIE INC. | 3 | $56.94 | |
| Apellis Pharmaceuticals, Inc. | 3 | $49.88 | |
| Astellas Pharma US Inc | 2 | $41.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
988
Patients
573
Total drug cost
$43,788
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketorolac Tromethamine | Generic | 393 | 297 | $7,890 |
| Prednisolone Acetate | Generic | 121 | 64 | $4,586 |
| Latanoprost | Generic | 92 | 25 | $1,308 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 90 | 78 | $1,316 |
| Timolol Maleate | Generic | 53 | 25 | $536 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 52 | 20 | $1,106 |
| Alphagan P (Brimonidine Tartrate) | Brand | 35 | 13 | $9,898 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 32 | 32 | $94 |
| Prolensa (Bromfenac Sodium) | Brand | 25 | 0 | $8,893 |
| Promethazine Hcl | Generic | 22 | 19 | $59 |
Hospital affiliations
Frequently asked questions
What is Dr. Tawan Khamapirad's medical specialty?
Dr. Tawan Khamapirad practices Ophthalmology Physician in Memphis, TN.
Where does Dr. Tawan Khamapirad practice?
Dr. Tawan Khamapirad practices at 6005 Park Ave, Memphis, TN 381195221. Office phone: 9016821100.
What is Dr. Tawan Khamapirad's NPI?
Dr. Tawan Khamapirad's National Provider Identifier (NPI) is 1689679441, issued by NPPES.
Does Dr. Tawan Khamapirad accept Medicare assignment?
Yes. Dr. Tawan Khamapirad accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tawan Khamapirad commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection of drug into eye (HCPCS 67028). Source: CMS Medicare Physician & Other Practitioners file.